OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.630
-0.140 (-7.91%)
At close: Apr 28, 2026, 4:00 PM EDT
1.680
+0.050 (3.07%)
After-hours: Apr 28, 2026, 7:28 PM EDT
OS Therapies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cost of Revenue | - | - | - | 0 | 1.16 | |
| Gross Profit | - | - | - | -0 | -1.16 | |
| Selling, General & Admin | 12.34 | 3.97 | 1.13 | 1.15 | 1.5 | |
| Research & Development | 16.36 | 2.84 | 3.22 | 3.29 | 2.17 | |
| Operating Expenses | 28.71 | 6.81 | 4.34 | 4.45 | 3.68 | |
| Operating Income | -28.71 | -6.81 | -4.34 | -4.45 | -4.84 | |
| Interest Expense | - | -2.05 | -3.45 | -1.81 | -2.58 | |
| Interest & Investment Income | 0 | - | 0 | - | - | |
| Other Non Operating Income (Expenses) | -0.05 | -0.02 | - | - | - | |
| Pretax Income | -28.75 | -8.88 | -7.79 | -6.25 | -7.42 | |
| Net Income | -28.75 | -8.88 | -7.79 | -6.25 | -7.42 | |
| Preferred Dividends & Other Adjustments | - | 0.03 | 0.13 | 0.13 | 0.09 | |
| Net Income to Common | -28.75 | -8.91 | -7.92 | -6.38 | -7.51 | |
| Shares Outstanding (Basic) | 29 | 7 | 5 | 10 | 10 | |
| Shares Outstanding (Diluted) | 29 | 7 | 5 | 10 | 10 | |
| Shares Change (YoY) | 320.90% | 28.01% | -45.60% | - | 18.50% | |
| EPS (Basic) | -0.98 | -1.28 | -1.46 | -0.64 | -0.75 | |
| EPS (Diluted) | -0.98 | -1.28 | -1.46 | -0.64 | -0.75 | |
| Free Cash Flow | -14.24 | -7.28 | -3.01 | -3.79 | -4.41 | |
| Free Cash Flow Per Share | -0.49 | -1.05 | -0.55 | -0.38 | -0.44 | |
| EBITDA | -28.34 | -6.81 | -4.34 | -4.45 | -4.84 | |
| D&A For EBITDA | 0.36 | 0 | 0 | 0 | 0 | |
| EBIT | -28.71 | -6.81 | -4.34 | -4.45 | -4.84 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.